Procept Biorobotics Corp. (($PRCT)) announced an update on their ongoing clinical study. Study Overview: The WATER IV Prostate Cancer study, ...
Q3 2025 Earnings Call Transcript October 29, 2025 AxoGen, Inc. beats earnings expectations. Reported EPS is $0.12, ...
Axogen, Inc. ( AXGN) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT ...
Understand the impact of robotic-assisted prostate cancer surgery and real-time analysis on surgical precision and patient ...
Stage 2 prostate cancer is considered localized, meaning the cancer is still confined entirely within the prostate gland and has not spread to nearby lymph nodes (node 0 or N0) or distant parts of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback